-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Veracyte, Raises Price Target to $48

Benzinga·02/26/2026 12:16:28
Listen to the news
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $44 to $48.